Senkyunolide N
CAS No. 140694-58-2
Senkyunolide N ( )
Catalog No. M32423 CAS No. 140694-58-2
Senkyunolide N exhibits prostaglandin H endoperoxide synthase-I (COX-I) and endoperoxide synthase-II (COX-II)) Inhibitory activity at pH 7 and at a concentration of 250 pg ml(-1) .
Purity : >98% (HPLC)
Size | Price / USD | Stock | Quantity |
10MG | 551 | In Stock |
|
50MG | Get Quote | In Stock |
|
100MG | Get Quote | In Stock |
|
Biological Information
-
Product NameSenkyunolide N
-
NoteResearch use only, not for human use.
-
Brief DescriptionSenkyunolide N exhibits prostaglandin H endoperoxide synthase-I (COX-I) and endoperoxide synthase-II (COX-II)) Inhibitory activity at pH 7 and at a concentration of 250 pg ml(-1) .
-
DescriptionSenkyunolide N exhibits prostaglandin H endoperoxide synthase-I (COX-I) and endoperoxide synthase-II (COX-II)) Inhibitory activity at pH 7 and at a concentration of 250 pg ml(-1) . Senkyunolide N exhibits topoisomerase-I and -II enzyme inhibitory activity at concentrations of 100, 200 and 200 microg ml(-1). Senkyolide N has insecticidal effect.
-
Synonyms
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number140694-58-2
-
Formula Weight226.3
-
Molecular FormulaC12H18O4
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Lupanine
Lupanine has a weak sedative effect on the central nervous system, interaction with specific drugs used for treatment of the CNS and for analgesic activity. Lupanine improves glucose homeostasis by influencing KATP-channels of pancreatic beta cells.
-
Ledene
Ledene is an essential oil produced by viridiflorene synthase. It has been studied as an antimicrobial, antioxidant, antibiofilm and to treat various cancers.
-
Osteogenic Growth Pe...
Osteogenic Growth Peptide, OGP is a short, naturally occurring 14-mer growth factor peptide found in serum at μM concentrations. Osteogenic growth peptide OGP is a key factor in the mechanism of the systemic osteogenic response to local bone marrow injury.